MoneyWorks4Me

Astrazeneca Pharma I - Quaterly Results

27 May 2024 Evaluate
The sales moved up 34.60% to Rs. 3831.99 millions for the March 2024 quarter as compared to Rs. 2847.04 millions during the year-ago period.The Total revenue for the quarter ended March 2024 of  Rs. 394.78  millions  grew by 128.58% from Rs. 172.71 millions.Operating profit for the quarter ended March 2024 decreased to 581.18 millions as compared to 678.46 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 3831.99 2847.04 34.60 12955.28 10029.71 29.17 12955.28 10029.71 29.17
Other Income 87.30 79.97 9.17 348.00 261.02 33.32 348.00 261.02 33.32
PBIDT 581.18 678.46 -14.34 2192.52 1912.27 14.66 2192.52 1912.27 14.66
Interest 0.00 0.88 0.00 12.01 6.33 89.73 12.01 6.33 89.73
PBDT 581.18 275.29 111.12 2344.77 1503.65 55.94 2344.77 1503.65 55.94
Depreciation 37.64 42.49 -11.41 149.40 162.60 -8.12 149.40 162.60 -8.12
PBT 543.54 232.80 133.48 2195.37 1341.05 63.71 2195.37 1341.05 63.71
TAX 148.76 60.09 147.56 580.28 348.12 66.69 580.28 348.12 66.69
Deferred Tax -6.39 -23.73 -73.07 -9.03 -34.90 -74.13 -9.03 -34.90 -74.13
PAT 394.78 172.71 128.58 1615.09 992.93 62.66 1615.09 992.93 62.66
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 15.17 23.83 -36.36 16.92 19.07 -11.24 16.92 19.07 -11.24
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..